Checchi Capital Advisers’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Checchi Capital Advisers’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,000	Closed	-$233K	–	554
2021 Q1	$233K	Buy	+8,000	New	+$224K	0.03%	450

Other funds holding NGM

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Rho Capital Partners New York $20.4M AUM

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Greenspring Associates Owings Mills, Maryland $1.48B AUM 61.93% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return

Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return

Aquilo Capital Management San Francisco, California $37.1M AUM 41.76% 1-Year Est. Return